<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">GSC</journal-id><journal-title-group><journal-title>Green and Sustainable Chemistry</journal-title></journal-title-group><issn pub-type="epub">2160-6951</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/gsc.2017.72013</article-id><article-id pub-id-type="publisher-id">GSC-76431</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Chemistry&amp;Materials Science</subject></subj-group></article-categories><title-group><article-title>
 
 
  Synthesis of the Prospective Anticancer Molecule Perillic Acid from Orange Essential Oil by the Yeast &lt;i&gt;Yarrowia lipolytica&lt;/i&gt;
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Marcelo</surname><given-names>R. R. Tappin</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Felipe</surname><given-names>M. Knopp</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Igor</surname><given-names>C. Cardoso</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Roberta</surname><given-names>T. Santos</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Bruna</surname><given-names>S. Drummond</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Antonio</surname><given-names>C. Siani</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Elba</surname><given-names>P. S. Bon</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Maria</surname><given-names>Antonieta Ferrara</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Institute of Drug Technology, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil</addr-line></aff><aff id="aff2"><addr-line>Chemistry Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>ferrara@far.fiocruz.br(MAF)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>15</day><month>03</month><year>2017</year></pub-date><volume>07</volume><issue>02</issue><fpage>172</fpage><lpage>184</lpage><history><date date-type="received"><day>April</day>	<month>26,</month>	<year>2017</year></date><date date-type="rev-recd"><day>Accepted:</day>	<month>May</month>	<year>22,</year>	</date><date date-type="accepted"><day>May</day>	<month>25,</month>	<year>2017</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  The bioconversion of the hydrophobic and volatile limonene to perillic acid, a potential anticancer agent, by the yeast Yarrowia lipolytica was studied in two steps. Firstly, experimental design was used for process optimization using high-purity limonene as substrate and secondly orange essential oil containing 89.1% limonene was used as substrate under the previously optimized conditions. Limonene concentration and pH were identified by fractional factorial design as significant factors and were optimized by central composite design. Under optimized process conditions (0.16% (v/v) limonene; pH 6.9), the 24 h biotransformation process resulted in the accumulation of 0.368 g&#183;L
  <sup>-1</sup> of perillic acid corresponding to a molar yield of 23.1%. A subsequent substrate addition under the same reaction conditions doubled perillic acid concentration to 0.793 g&#183;L
  <sup>-1</sup> and a molar yield of 24.2%. The use of orange essential oil under the optimized reaction conditions increased both perillic acid accumulation and yield to 0.872 g&#183;L
  <sup>-1</sup> and 29.7%, respectively. The robustness of Y. lipolytica allowed the efficient biotransformation of a crude by-product of the citrus industry into a valuable fine chemical.
 
</p></abstract><kwd-group><kwd>&lt;i&gt;Yarrowia lipolytica&lt;/i&gt;</kwd><kwd> Bioconversion</kwd><kwd> Perillic Acid</kwd><kwd> Limonene</kwd><kwd> Orange Essential Oil</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>The compounds perillyl alcohol, perillaldehyde and perillic acid, derived from the limonene molecule through the oxidation of its exocyclic methyl group, are known for presenting several biological activities. Perillaldehyde presents antimicrobial property [<xref ref-type="bibr" rid="scirp.76431-ref1">1</xref>] and perillyl alcohol is currently on clinical trials as a multi-target anti-cancer agent [<xref ref-type="bibr" rid="scirp.76431-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.76431-ref3">3</xref>] . The prospective anticancer activity of perillic acid relates to the accepted mechanism for these monoterpenes as inhibitors of protein prenylation in cancer cells [<xref ref-type="bibr" rid="scirp.76431-ref4">4</xref>] as well as its presence in human plasma after limonene [<xref ref-type="bibr" rid="scirp.76431-ref5">5</xref>] or perillyl alcohol [<xref ref-type="bibr" rid="scirp.76431-ref6">6</xref>] administration. Indeed, perillic acid has demonstrated to be effective in a range of antitumor in vitro assays [<xref ref-type="bibr" rid="scirp.76431-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.76431-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.76431-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.76431-ref10">10</xref>] .</p><p>With rare exceptions [<xref ref-type="bibr" rid="scirp.76431-ref11">11</xref>] volatile monoterpenes in plants present low perillic derivatives content since the O<sub>2</sub>/NADPH-dependent biosynthetic step to hydro- xylate the limonene moiety in plant cells is known to produce complex mixtures of perillyl, carvyl and menthyl alcohols [<xref ref-type="bibr" rid="scirp.76431-ref12">12</xref>] . Furthermore, perillic derivatives are difficult to obtain by chemical oxidation of limonene, given that the insertion of oxygen into the terminal methyl group is less favourable in comparison to other sites of the molecule. In fact, the allylic hydroxylation of limonene catalyzed by either palladium compounds [<xref ref-type="bibr" rid="scirp.76431-ref13">13</xref>] or metal silicates [<xref ref-type="bibr" rid="scirp.76431-ref14">14</xref>] is highly favored to take place in the cyclic carbons rather than the terminal methyl group of limonene molecule, to generate menthol and carveol isomers.</p><p>Nevertheless, several studies on the microbial or enzymatic bio-oxidation of limonene have shown effectiveness to oxyfunctionalize exclusively the exocyclic methyl group for the production of perillic acid [<xref ref-type="bibr" rid="scirp.76431-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.76431-ref16">16</xref>] . Biotransformation processes using wild type or genetically modified Pseudomonas putida cells have shown to be quite promising for the production of perillic acid as a molecule of industrial interest for natural preservation and pharmaceutical application [<xref ref-type="bibr" rid="scirp.76431-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.76431-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.76431-ref19">19</xref>] . Studies on this theme included the use of a tubular segmented-flow biofilm reactor in a multistep process with high productivity [<xref ref-type="bibr" rid="scirp.76431-ref19">19</xref>] . Investigations have also been carried out with the bacteria Escherichia and Mycobacterium [<xref ref-type="bibr" rid="scirp.76431-ref16">16</xref>] . The fungus Aspergillus cellulosae [<xref ref-type="bibr" rid="scirp.76431-ref16">16</xref>] and the non-conventional yeasts Arxula adeninivorans and Yarrowia lipolytica [<xref ref-type="bibr" rid="scirp.76431-ref20">20</xref>] have also been approached to converting limonene to perillic derivatives. Recently, our research group successfully studied the bio-oxidation of R-(+)-limonene into R-(+)-perillic acid by Y. lipolytica ATCC 18942 [<xref ref-type="bibr" rid="scirp.76431-ref21">21</xref>] , which is recognized as safe and suitable yeast to be used in processes aiming at products for human consumption [<xref ref-type="bibr" rid="scirp.76431-ref22">22</xref>] [<xref ref-type="bibr" rid="scirp.76431-ref23">23</xref>] . As a continuation of the previous study, the present work aimed to increase the perillic acid yield from high-purity limonene, by applying statistical design of experiments to the bioreaction parameters. Finally, the optimized biotransformation conditions were applied to a crude orange essential oil sample representing an industrial terpenoid mixture containing 83% to 97% of R-(+)-limonene.</p></sec><sec id="s2"><title>2. Materials and Methods</title><sec id="s2_1"><title>2.1. Microorganism, Media, Yeast Cultivation and Bioconversion Assays</title><p>Y. lipolytica ATCC 18942 was obtained from the National Institute for Quality Control in Health, Oswaldo Cruz Foundation collection (INCQS 40149, Fiocruz, Rio de Janeiro, Brazil). Cells were grown in Yeast Malt Broth medium (glucose 10 g∙L<sup>−</sup><sup>1</sup>, yeast extract 3 g∙L<sup>−</sup><sup>1</sup>, malt extract 3 g∙L<sup>−</sup><sup>1</sup> and peptone 5 g∙L<sup>−</sup><sup>1</sup>) at 28˚C under stirring (200 rpm) during 48 h. For the bioconversion experiments, cells were separated by centrifugation (3000 &#180; g) and re-suspended in phosphate buffer (50 mM) at 20 g∙L<sup>−</sup><sup>1</sup>. R-(+)-limonene 97% (Sigma) was added and the mixture was incubated under stirring at 200 rpm. Temperature, pH, nutrient addition and limonene concentration were the factors selected for experimental design and their values varied through the experiments.</p></sec><sec id="s2_2"><title>2.2. Experimental Design</title><p>A fractional factorial design [<xref ref-type="bibr" rid="scirp.76431-ref24">24</xref>] was carried out for screening significant factors for limonene bioconversion to perillic acid. Process temperature, process pH, initial R-(+)-limonene concentration and nutrient addition were selected at the levels shown in <xref ref-type="table" rid="table1">Table 1</xref>. The experiments were performed in duplicate and perillic acid concentration, measured at 24 h and 48 h, was the response variable.</p><p>For the bioconversion optimization, a central composite design [<xref ref-type="bibr" rid="scirp.76431-ref24">24</xref>] was carried out having initial R-(+)-limonene concentration and pH as variables at the levels shown in <xref ref-type="table" rid="table2">Table 2</xref>. Nutrients were not added and the temperature was kept at 25˚C. Experiments were performed in non-simultaneous triplicate and aliquots of the bioconversion medium were collected at 24 and 48 h for perillic acid quantification. Two responses (dependent variables) were considered for the statistical analysis: perillic acid concentration and molar bioconversion yield (which considers perillic acid production related to the initial limonene concentration). For each response at each time (24 h and 48 h), the prediction model was calculated such as:</p><disp-formula id="scirp.76431-formula290"><graphic  xlink:href="http://html.scirp.org/file/6-5500288x2.png"  xlink:type="simple"/></disp-formula><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Trial of variables by fractional factorial design: cell mass fixed at 20 g∙L<sup>−</sup><sup>1</sup></title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle"  colspan="4"  >Variables and levels</th></tr></thead><tr><td align="center" valign="middle" >Run</td><td align="center" valign="middle" >T (˚C)</td><td align="center" valign="middle" >pH</td><td align="center" valign="middle" >Initial Limonene concentration (% v/v)</td><td align="center" valign="middle" >Nutrients * (% v/v)</td></tr><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >− (20.0)</td><td align="center" valign="middle" >? (6.2)</td><td align="center" valign="middle" >? (0.1)</td><td align="center" valign="middle" >? (0)</td></tr><tr><td align="center" valign="middle" >2</td><td align="center" valign="middle" >? (20.0)</td><td align="center" valign="middle" >? (6.2)</td><td align="center" valign="middle" >+ (0.5)</td><td align="center" valign="middle" >+ (10)</td></tr><tr><td align="center" valign="middle" >3</td><td align="center" valign="middle" >? (20.0)</td><td align="center" valign="middle" >+ (7.2)</td><td align="center" valign="middle" >? (0.1)</td><td align="center" valign="middle" >+ (10)</td></tr><tr><td align="center" valign="middle" >4</td><td align="center" valign="middle" >? (20.0)</td><td align="center" valign="middle" >+ (7.2)</td><td align="center" valign="middle" >+ (0.5)</td><td align="center" valign="middle" >? (0)</td></tr><tr><td align="center" valign="middle" >5</td><td align="center" valign="middle" >+ (25.0)</td><td align="center" valign="middle" >? (6.2)</td><td align="center" valign="middle" >? (0.1)</td><td align="center" valign="middle" >+ (10)</td></tr><tr><td align="center" valign="middle" >6</td><td align="center" valign="middle" >+ (25.0)</td><td align="center" valign="middle" >? (6.2)</td><td align="center" valign="middle" >+ (0.5)</td><td align="center" valign="middle" >? (0)</td></tr><tr><td align="center" valign="middle" >7</td><td align="center" valign="middle" >+ (25.0)</td><td align="center" valign="middle" >+ (7.2)</td><td align="center" valign="middle" >? (0.1)</td><td align="center" valign="middle" >? (0)</td></tr><tr><td align="center" valign="middle" >8</td><td align="center" valign="middle" >+ (25.0)</td><td align="center" valign="middle" >+ (7.2)</td><td align="center" valign="middle" >+ (0.5)</td><td align="center" valign="middle" >+ (10)</td></tr><tr><td align="center" valign="middle" >9</td><td align="center" valign="middle" >0 (22.5)</td><td align="center" valign="middle" >0 (6.7)</td><td align="center" valign="middle" >0 (0.3)</td><td align="center" valign="middle" >0 (5)</td></tr><tr><td align="center" valign="middle" >10</td><td align="center" valign="middle" >0 (22.5)</td><td align="center" valign="middle" >0 (6.7)</td><td align="center" valign="middle" >0 (0.3)</td><td align="center" valign="middle" >0 (5)</td></tr><tr><td align="center" valign="middle" >11</td><td align="center" valign="middle" >0 (22.5)</td><td align="center" valign="middle" >0 (6.7)</td><td align="center" valign="middle" >0 (0.3)</td><td align="center" valign="middle" >0 (5)</td></tr></tbody></table></table-wrap><p>*Nutrients solution: 3 g∙L<sup>−</sup><sup>1</sup> yeast extract, 3 g∙L<sup>−</sup><sup>1</sup> malt extract, 5 g∙L<sup>−</sup><sup>1</sup> peptone, 10 g∙L<sup>−</sup><sup>1</sup> glucose.</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Optimization by central composite design. Cell mass was fixed at 20 g∙L<sup>−</sup><sup>1</sup> and temperature at 25˚C</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle"  colspan="2"  >Variables and levels</th></tr></thead><tr><td align="center" valign="middle" >Run</td><td align="center" valign="middle" >Limonene (% v/v)</td><td align="center" valign="middle" >pH</td></tr><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >? (0.16)</td><td align="center" valign="middle" >? (6.35)</td></tr><tr><td align="center" valign="middle" >2</td><td align="center" valign="middle" >? (0.16)</td><td align="center" valign="middle" >+ (7.05)</td></tr><tr><td align="center" valign="middle" >3</td><td align="center" valign="middle" >+ (0.44)</td><td align="center" valign="middle" >? (6.35)</td></tr><tr><td align="center" valign="middle" >4</td><td align="center" valign="middle" >+ (0.44)</td><td align="center" valign="middle" >+ (7.05)</td></tr><tr><td align="center" valign="middle" >5</td><td align="center" valign="middle" >a (0.10)</td><td align="center" valign="middle" >0 (6.7)</td></tr><tr><td align="center" valign="middle" >6</td><td align="center" valign="middle" >A (0.50)</td><td align="center" valign="middle" >0 (6.7)</td></tr><tr><td align="center" valign="middle" >7</td><td align="center" valign="middle" >0 (0.30)</td><td align="center" valign="middle" >a (6.2)</td></tr><tr><td align="center" valign="middle" >8</td><td align="center" valign="middle" >0 (0.30)</td><td align="center" valign="middle" >A (7.2)</td></tr><tr><td align="center" valign="middle" >9</td><td align="center" valign="middle" >0 (0.30)</td><td align="center" valign="middle" >0 (6.7)</td></tr><tr><td align="center" valign="middle" >10</td><td align="center" valign="middle" >0 (0.30)</td><td align="center" valign="middle" >0 (6.7)</td></tr><tr><td align="center" valign="middle" >11</td><td align="center" valign="middle" >0 (0.30)</td><td align="center" valign="middle" >0 (6.7)</td></tr></tbody></table></table-wrap><p>where ŷ is the predicted response, b<sub>0</sub> is the intercept, b<sub>Lim</sub> is the linear coefficient of the limonene concentration, x<sub>Lim</sub> is the codified value of the limonene concentration, b<sub>pH</sub> is the linear coefficient of the pH, x<sub>pH</sub> is the codified value of the pH, b<sub>LimpH</sub> is the coefficient for the interaction between limonene concentration and pH, <inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/6-5500288x3.png" xlink:type="simple"/></inline-formula>is the quadratic coefficient of the limonene concentration, <inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/6-5500288x4.png" xlink:type="simple"/></inline-formula>is the quadratic coefficient of pH value. Design settings and calculations were performed in JMP Statistical Discovery Software version 8.</p></sec><sec id="s2_3"><title>2.3. Stepwise Addition of Limonene</title><p>The conditions optimized by central composite design, pH 6.9 and R-(+)-limo- nene concentration of 0.16% (v/v) were applied in a bioconversion experiment where a fresh equal R-(+)-limonene dose was added after 24 h. Aliquots were collected at 24 h and 48 h for perillic acid concentration measurement. Experiment was performed in duplicate.</p></sec><sec id="s2_4"><title>2.4. Use of Orange Essential Oil for the Production of Perillic Acid</title><p>The high-purity limonene optimized process conditions were applied to the bioconversion of the orange essential oil (from Tropfruit Nordeste S. A, Est&#226;ncia, Brazil). This substrate was added to the yeast medium in two portions (2 &#215; 0.16% v/v, pH 6.9) at the beginning and after 24 h of bioconversion. Overall yield was taken after 48 h reaction.</p></sec><sec id="s2_5"><title>2.5. Analytical Procedures</title><p>Cell mass concentration was determined by optical density at 600 nm (OD<sub>600</sub>). One OD<sub>600</sub> unit corresponded to a dry cell concentration of 0.444 g∙L<sup>−</sup><sup>1</sup>. Glucose concentration was measured using an YSI 2700 Select Biochemistry Analyzer (Yellow Springs). Perillic acid was determined by gas chromatography (GC) using (S)-(-)-perillic acid 95% from Sigma-Aldrich as standard. A sample of the bioconversion supernatant was cleared of debris by centrifuging 15 min at 15000 &#180; g and a 1.00 mL supernatant aliquot was transferred to a 1.7 mL microcentrifuge tube (tube 1). Perillic acid was precipitated by adding 100 &#181;l of HCl 0.6 M solution and the resulting suspension was homogenized and centrifuged at 15000 &#180; g during 15 minutes. The supernatant was transferred to another 1.7 mL microcentrifuge tube and after repeating the precipitation procedure, the supernatant was discarded. The precipitates from both tubes were dissolved with ethyl acetate and transferred to a 2.00 mL volumetric flask that was filled up with the same solvent. After homogenization the perillic acid solution was analyzed using a GC instrument from Agilent Technologies model 7890 equipped with a 7683 injector and autosampler, split/splitless injector and flame ionization detector (Santa Clara, USA). A J &amp; W Scientific HP-Innowax column with a bonded polyethylene glycol phase, 30 m length, 250 &#181;m internal diameter and 0.250 &#181;m film thickness, was used. All analyses were performed using a temperature program, constant flow, and split injection. The chromatographic conditions were as follows: oven temperature initiated at 50˚C, temperature increasing to 250˚C at 20˚C min<sup>−</sup><sup>1</sup>, held for 5 min; the run time was 15 min. The injector temperature was set at 280˚C, and detector temperature set at 300˚C. Helium was the carrier gas at a flow rate of 1 mL∙min<sup>−</sup><sup>1</sup>. Injection volume was 1.0 &#181;l with the split ratio set at 25:1.</p><p>Limonene content in the crude orange essential oil was determined by GC using R-(+)-limonene 97% from Sigma as standard. GC-column was a DB-5 30 m length, 250 &#181;m internal diameter and 0.250 &#181;m film thickness. The chromatographic conditions were as follows: the oven temperature was kept at 70˚C for 5 min and then increased at 4˚C min<sup>−</sup><sup>1</sup> up to 170˚C; the run time was 30 min. The injector was set at 250˚C and the detector at 300˚C. Helium was the carrier gas at a flow rate of 0.5 mL∙min<sup>−</sup><sup>1</sup>. Injection volume was 1.0 &#181;l with the split ratio set at 50:1.</p></sec></sec><sec id="s3"><title>3. Results</title><sec id="s3_1"><title>3.1. Screening of Variables Using Experimental Design</title><p>Previous results from our laboratory showed the yeast cell mass and limonene concentrations, pH, temperature and nutrient addition as relevant variables to be assessed for limonene bioconversion to perillic acid, as well as their range values [<xref ref-type="bibr" rid="scirp.76431-ref21">21</xref>] . Cell mass concentration, assayed to sub-levels 5.0 - 12.5 - 20.0 g∙L<sup>−</sup><sup>1</sup> in a preliminary fractional factorial design experiment, showed a preponderant influence on the response, impairing the assessment of the remaining variables (data not shown). Hence, the screening was designed by fixing the cell mass concentration at 20 g∙L<sup>−</sup><sup>1</sup> and varying the other factors as shown in <xref ref-type="table" rid="table1">Table 1</xref>.</p><p>The statistical analysis (<xref ref-type="fig" rid="fig1">Figure 1</xref>) showed that the most relevant factors were the limonene concentration followed by the pH. In the range assayed, the temperature was of low significance at 24 h and non-significant at 48 h. Therefore,</p><fig id="fig1"  position="float"><label><xref ref-type="fig" rid="fig1">Figure 1</xref></label><caption><title> Significance chart for the assessed factors in the fractional factorial design for the bioconversion of limonene to perillic acid</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/6-5500288x5.png"/></fig><p>for the subsequent experiments, the temperature was fixed at 25˚C. The addition of a nutrient solution (containing macro-micronutrients, and growth factors that would be required for cell maintenance and/or enzymatic activity) was not significant for the perillic acid production, even though glucose, when present, was fully metabolized (data not shown). This result indicated that the bioconversion could be carried out without appending extra nutrients to the medium.</p></sec><sec id="s3_2"><title>3.2. Optimization Using Response Surface Methodology</title><p>Process optimization with the two selected variables, limonene concentration and pH, was performed by central composite design according to <xref ref-type="table" rid="table2">Table 2</xref>. <xref ref-type="fig" rid="fig2">Figure 2</xref> shows the effects of the factors on perillic acid concentration and on the bioconversion molar yield at 24 h and 48 h. The linear and the quadratic effects of limonene concentration were significant for perillic acid concentration at both time intervals. When considering the yield as the response variable, the linear effect of limonene concentration was significant at 24 h while the quadratic effect was significant at 48 h. PH effects in the range assayed were not significant for both responses in this experiment. Predictive models were generated for each response (product concentration and molar bioconversion yield) as shown in <xref ref-type="table" rid="table3">Table 3</xref>. The profiles displayed in <xref ref-type="fig" rid="fig3">Figure 3</xref> and <xref ref-type="fig" rid="fig4">Figure 4</xref> showed that the optimum conditions were different according to the type of response evaluated thereof. The overall maximum predicted perillic acid concentration (0.868 &#177; 0.076 g∙L<sup>−1</sup>) was reached with 0.44% (v/v) initial limonene concentration and pH 6.94 at 48 h (<xref ref-type="fig" rid="fig4">Figure 4</xref>(a)). Nevertheless, this value was only 23% higher than the maximum predicted at 24 h (0.706 &#177; 0.062 g∙L<sup>−1</sup>) for 0.40% (v/v) limonene concentration and pH 6.96 (<xref ref-type="fig" rid="fig3">Figure 3</xref>(a)). The predicted bioconversion yields for these conditions were 20.4% &#177; 2.6% and 18.4% &#177; 2.2%, respectively. On the other</p><fig id="fig2"  position="float"><label><xref ref-type="fig" rid="fig2">Figure 2</xref></label><caption><title> Effects graph for the assessed factors in the central composite design</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/6-5500288x6.png"/></fig><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Prediction models for each response</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Response</th><th align="center" valign="middle" >Prediction model</th></tr></thead><tr><td align="center" valign="middle" >Perillic acid concentration (g∙L<sup>−1</sup>) 24 h</td><td align="center" valign="middle" >ŷ = 0.64891438888889 + 0.12883473167398x<sub>Lim</sub> + 0.03545373207567x<sub>pH</sub> + 0.01050779166667x<sub>Lim</sub>x<sub>pH</sub> − 0.0995462777778<inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/6-5500288x7.png" xlink:type="simple"/></inline-formula> − 0.0287720694444<inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/6-5500288x8.png" xlink:type="simple"/></inline-formula></td></tr><tr><td align="center" valign="middle" >Bioconversion yield (%) 24 h</td><td align="center" valign="middle" >ŷ = 21.0544323390805 − 4.7538065958408x<sub>Lim</sub> + 1.11120440122768x<sub>pH</sub> + 0.16644282070712x<sub>Lim</sub>x<sub>pH</sub> − 1.0815310302604<inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/6-5500288x9.png" xlink:type="simple"/></inline-formula> − 0.8475487296127<inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/6-5500288x10.png" xlink:type="simple"/></inline-formula></td></tr><tr><td align="center" valign="middle" >Perillic acid concentration (g∙L<sup>−1</sup>) 48 h</td><td align="center" valign="middle" >ŷ = 0.72121044444444 + 0.23301431549124x<sub>Lim</sub> + 0.019971336804x<sub>pH</sub> + 0.02817066666667x<sub>Lim</sub>x<sub>pH</sub> − 0.1028183680556<inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/6-5500288x11.png" xlink:type="simple"/></inline-formula> − 0.0348015347222<inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/6-5500288x12.png" xlink:type="simple"/></inline-formula></td></tr><tr><td align="center" valign="middle" >Bioconversion yield (%) 48 h</td><td align="center" valign="middle" >ŷ = 23.4001229820067 − 1.1416892754269x<sub>Lim</sub> + 0.47061378146558x<sub>pH</sub> + 0.75476044841651x<sub>Lim</sub>x<sub>pH</sub> − 2.9209782138728<inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/6-5500288x13.png" xlink:type="simple"/></inline-formula> − 1.0075914617546<inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/6-5500288x14.png" xlink:type="simple"/></inline-formula></td></tr></tbody></table></table-wrap><p>hand, the maximum predicted bioconversion yields were 25.7% &#177; 2.4% (0.428 &#177; 0.069 g∙L<sup>−1</sup> perillic acid) at 24 h (<xref ref-type="fig" rid="fig3">Figure 3</xref>(b)) and 24.3% &#177; 2.3% (0.681 &#177; 0.067 g∙L<sup>−1</sup> perillic acid) at 48 h (<xref ref-type="fig" rid="fig4">Figure 4</xref>(b)) at much lower limonene concentrations, 0.16% (pH 6.9) and 0.28% (pH 6.76), respectively. The fact that the higher limonene concentrations resulted in lower bioconversion yields could be assigned to the limonene toxicity towards the yeast cells as well as to its volatility. These effects had already been described during previous limonene bio-oxidation studies</p><fig id="fig3"  position="float"><label><xref ref-type="fig" rid="fig3">Figure 3</xref></label><caption><title> Profiles of the measured responses at 24 h: (a) optimum conditions for perillic acid concentration; (b) optimum conditions for bioconversion yield</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/6-5500288x15.png"/></fig><p>[<xref ref-type="bibr" rid="scirp.76431-ref21">21</xref>] . The pH was not significant for the measured responses at 24 and 48 h. Nevertheless, this parameter was included in the predictive model.</p></sec><sec id="s3_3"><title>3.3. Stepwise Addition of Limonene</title><p>The statistical modeling indicated that the use of 0.16% limonene allowed the maximum molar yield within 24 h bioconversion suggesting that this initial limonene concentration coupled to a fresh limonene addition after 24 h might increase perillic acid concentration while keeping the bioconversion yield. To assess this possibility, a new test was conducted using 0.16% limonene at pH 6.9 followed by an equal limonene addition after 24 h. The product concentration reached 0.368 g∙L<sup>−1</sup> perillic acid (23.1% yield) after 24 h, within the model prediction interval between 0.358 g∙L<sup>−1</sup> and 0.496 g∙L<sup>−1</sup>. After the second limonene</p><fig id="fig4"  position="float"><label><xref ref-type="fig" rid="fig4">Figure 4</xref></label><caption><title> Profiles of the measured responses at 48 h: (a) optimum conditions for perillic acid concentration; (b) optimum conditions for bioconversion yield</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/6-5500288x16.png"/></fig><p>addition, the bioconversion process resumed reaching 0.793 g∙L<sup>−1</sup> of perillic acid (24.2% yield) within 48 h of the total bioconversion process. The two steps limonene addition resulted advantageous either comparing with the intermittent six-portions limonene feeding used in the previous study (0.5% total over 48 h; perillic acid concentration increasing by 50%) or to the total single limonene addition at the beginning of the experiment. Furthermore, the present study improved the reaction molar yield by 1.5 fold in comparison to the previous maximum yield of 16.7% [<xref ref-type="bibr" rid="scirp.76431-ref21">21</xref>] .</p></sec><sec id="s3_4"><title>3.4. Bioconvertion of Orange Essential Oil into Perillic Acid</title><p>The optimized conditions found to the bioconversion of high-purity limonene with Yarrowia lipolytica were replicated by using orange essential oil containing 89.1% limonene. Within 48 h bioconversion, an accumulation of 0.872 g∙L<sup>−1</sup> of perillic acid (29.7% molar yield) was achieved; these values being higher than the observed for the use of high-purity limonene. The yield increase could be due to better substrate dispersion, as visually observed. In fact, crude orange oil pre- sents a large variety of components such as oxidized derivatives of other mono- terpenes and sesquiterpenes (data not shown) [<xref ref-type="bibr" rid="scirp.76431-ref25">25</xref>] that, nevertheless in minor amounts, would increase the availability of the limonene molecule to the yeast cells.</p></sec></sec><sec id="s4"><title>4. Discussion</title><p><xref ref-type="table" rid="table4">Table 4</xref> compares published data from our laboratory [<xref ref-type="bibr" rid="scirp.76431-ref21">21</xref>] and data from the present work regarding the main biotransformation process parameters in terms of reaction conditions, perillic acid final concentration and perillic acid molar yield. The handling of volatile limonene to enhance its bioavailability to the yeast cells in a stirred-process of bioconversion, without using emulsifiers, turned out to be quite challenging. Thus, six limonene additions to the reaction medium had been done over a period of 48 h in our previous work [<xref ref-type="bibr" rid="scirp.76431-ref21">21</xref>] . In the present study however, only two additions were needed, which meant an operational gain, without decreasing the final product concentration. Although the product concentrations obtained by the three reaction conditions presented in <xref ref-type="table" rid="table4">Table 4</xref> were very similar, with an average value of 0.85 g∙L<sup>−1</sup>, the molar yields increased 50% and 78% in the optimized process by using high-purity limonene or the orange oil as substrate, respectively. The use of lower substrate amounts of 35% for high-purity limonene and 41% for crude orange oil represented a significant feedstock saving, an important issue regarding cost and process sustainability.</p><p><xref ref-type="table" rid="table4">Table 4</xref> also compares the cost of the high-purity limonene or orange oil substrates, for the production of 1 Kg of perillic acid. The biotransformation process using orange oil resulted in an important decrease in the cost from either 552.38</p><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Comparison of the main biotransformation process parameters, production data of perillic acid (PA) by Yarrowia lipolytica and substrate cost for the use of high-purity limonene (published data and present study) and orange oil (data from the present study)</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Measured parameter</th><th align="center" valign="middle" >Previous process<sup>1</sup></th><th align="center" valign="middle"  colspan="2"  >Optimized process<sup>2</sup></th></tr></thead><tr><td align="center" valign="middle" >Limonene (96% purity)</td><td align="center" valign="middle" >Limonene (97% purity)</td><td align="center" valign="middle" >Orange oil (89% limonene)</td></tr><tr><td align="center" valign="middle" >Bioconversion conditions</td><td align="center" valign="middle" >25˚C; pH 7.1; 10 g∙L cell mass (dry weight)</td><td align="center" valign="middle"  colspan="2"  >25˚C; pH 6.9; 20 g/L cell mass (dry weight)</td></tr><tr><td align="center" valign="middle" >Total limonene amount (mM)<sup>3</sup></td><td align="center" valign="middle" >29.7 (4.0 g∙L<sup>−1</sup>)</td><td align="center" valign="middle" >19.2 (2.6 g∙L<sup>−1</sup>)</td><td align="center" valign="middle" >17.6 (2.4 g∙L<sup>−1</sup>)</td></tr><tr><td align="center" valign="middle" >Limonene addition mode over 48 h</td><td align="center" valign="middle" >6 additions</td><td align="center" valign="middle" >2 additions</td><td align="center" valign="middle" >2 additions</td></tr><tr><td align="center" valign="middle" >Final PA concentration</td><td align="center" valign="middle" >0.855 g∙L<sup>−1</sup></td><td align="center" valign="middle" >0.796 g∙L<sup>−1</sup></td><td align="center" valign="middle" >0.872 g.L<sup>−1</sup></td></tr><tr><td align="center" valign="middle" >PA molar yield</td><td align="center" valign="middle" >16.7%</td><td align="center" valign="middle" >25,0%</td><td align="center" valign="middle" >29.7%</td></tr><tr><td align="center" valign="middle" >Cost of limonene substrate to produce 1 Kg PA</td><td align="center" valign="middle" >552.38 USD<sup>4</sup></td><td align="center" valign="middle" >386.67 USD<sup>4</sup></td><td align="center" valign="middle" >80.56 USD<sup>4</sup> 12.90 USD<sup>5</sup></td></tr></tbody></table></table-wrap><p><sup>1</sup>See ref. [<xref ref-type="bibr" rid="scirp.76431-ref21">21</xref>] . <sup>2</sup>Optimized conditions using experimental design (this work). <sup>3</sup>Calculated considering the substrate purity degree. <sup>4</sup>Estimated from prices of (R)-(+)-limonene and orange oil from Sigma-Aldrich. <sup>5</sup>Estimated from price of orange oil from the Brazilian Company Tropfruit Nordeste S. A.</p><p>USD (non-optimized process) or 386.67 USD (optimized process) for high-pu- rity limonene to 80.56 USD or 12.90 USD for imported or Brazil produced orange oil.</p><p>These results are quite valuable due to the present industrial scenario where low-cost industrial feedstocks are particularly at aim for supplying the fine chemical-based industries [<xref ref-type="bibr" rid="scirp.76431-ref26">26</xref>] . Orange essential oil is largely available due to a worldwide orange production of 70 million tons per year [<xref ref-type="bibr" rid="scirp.76431-ref27">27</xref>] . The orange-based industry (28 million tons/year) by itself generates residues amounting 50% of the raw processed fruit whereby the orange oil represents approximately 5% (on dry basis) [<xref ref-type="bibr" rid="scirp.76431-ref28">28</xref>] and can be obtained directly from the cold pressing citrus zests. In this scenario, the large availability of orange essential oil coupled to an environmentally friendly yeast based process to produce perillic acid could be extensively explored to establish a cost-effective synthesis of pharmaceutically valuable molecules. It is also relevant to stress the particular characteristics of Y. lipolytica as a robust yeast able to assimilate a great diversity of substrates, being tolerant to pollutants [<xref ref-type="bibr" rid="scirp.76431-ref22">22</xref>] [<xref ref-type="bibr" rid="scirp.76431-ref23">23</xref>] and thus very attractive to industrial use. Besides, the easiness of yeast separation from the biotransformation reaction mixture, as compared to bacteria, is another advantage for the process scale up.</p></sec><sec id="s5"><title>5. Conclusion</title><p>The use of statistical design of experiments allowed determining how each reaction condition influenced the selective bio-oxidation of the limonene molecule in order to maximize the formation of perillic acid using a minimum amount of substrate. This approach resulted in 24.2% bioconversion yield on limonene basis, representing an increase of 1.5 fold, as compared to previous reported results. The aforementioned process conditions were applied to orange essential oil, increasing the molar yield even further to 29.7% corresponding to 0.872 g∙L<sup>−1</sup> of perillic acid, showing the robustness of Y. lipolytica towards this new substrate. The process feasibility using a highly-available industrial feedstock to produce a valuable fine chemical is promising due to the well-known advantages embodied by a green chemistry process as well as to the strategic and cost advantages conveyed by the use of a citrus industry by-product.</p></sec><sec id="s6"><title>Acknowledgements</title><p>This research was supported by Funda&#231;&#227;o de Amparo &#224; Pesquisa do Estado do Rio de Janeiro (FAPERJ), Grant E-26/110.856/2013.</p></sec><sec id="s7"><title>Cite this paper</title><p>Tappin, M.R.R., Knopp, F.M., Cardoso, I.C., Santos, R.T., Drummond, B.S., Siani, A.C., Bon, E.P.S. and Ferrara, M.A. (2017) Synthesis of the Prospective Anticancer Molecule Perillic Acid from Orange Essential Oil by the Yeast Yarrowia lipolytica. Green and Sustainable Chemistry, 7, 172-184. https://doi.org/10.4236/gsc.2017.72013</p></sec></body><back><ref-list><title>References</title><ref id="scirp.76431-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Kang, R., Heims, R., Stout, M.J., Jaber, H., Chen, Z. and Nakatsu, T. (1992) Antimicrobial Activity of the Volatile Constituents of Perilla frutescens and Its Synergistic Effect with Polygodial. Journal of Agricultural and Food Chemistry, 40, 2328-2330.  
&lt;br /&gt;https://doi.org/10.1021/jf00023a054</mixed-citation></ref><ref id="scirp.76431-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Da Silveira, F.C.A., Lopes, B.A., Fonseca, C.O., Quirico-Santos, T., Paix&amp;atilde;o, I.C.N.P. and Amorim, L.M.F. (2012) Analysis of EGF + 61A &gt; G polymorphism and EGF Serum Levels in Brazilian Glioma Patients Treated with Perillyl Alcohol-Based Therapy. Journal of Cancer Research and Clinical Oncology, 138, 1347-1354.  
&lt;br /&gt;https://doi.org/10.1007/s00432-012-1203-5</mixed-citation></ref><ref id="scirp.76431-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Silva, M.M., Da Fonseca, C.O., Moura-Neto, R., Carvalho, J.F., Quirico-Santos, T. and Carvalho, M.G. (2013) Influence of GSTM1 and GSTT1 Polymorphisms on the Survival Rate of Patients with Malignant Glioma under Perillyl Alcohol-Based Therapy. Genetics and Molecular Research, 12, 1621-1630.   
&lt;br /&gt;https://doi.org/10.4238/2013.May.14.2</mixed-citation></ref><ref id="scirp.76431-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Gelb, M.H., Tamanoi, F., Yokoyama, K., Ghomashchi, F., Esson, K. and Gould, M. N. (1995) The Inhibition of Protein Prenyltransferases by Oxygenated Metabolites of Limonene and Perillyl Alcohol. Cancer Letters, 91, 169-175.  
&lt;br /&gt;https://doi.org/10.1016/0304-3835(95)03747-K</mixed-citation></ref><ref id="scirp.76431-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Chow, H.S., Salazar, D. and Hakim, I.A. (2002) Pharmacokinetics of Perillic Acid in Humans after a Single Dose Administration of a Citrus Preparation Rich in D-Li- monene Content. Cancer Epidemiology and Prevention Biomarkers, 11, 1472-1476.</mixed-citation></ref><ref id="scirp.76431-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Yeruva, L., Pierre, K.J., Elegbede, A., Wang, R.C. and Carper, S.W. (2007) Perillyl Alcohol and Perillic Acid Induced Cell Cycle and Apoptosis in Non-Small Cell Lung Cancer. Cancer Letters, 257, 216-226. &lt;br /&gt;https://doi.org/10.1016/j.canlet.2007.07.020</mixed-citation></ref><ref id="scirp.76431-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Bardona, S., Foussardb, V., Fournelb, S. and Loubat, A. (2002) Monoterpenes Inhibit Proliferation of Human Colon Cancer Cells by Modulating Cell Cycle-Related Protein Expression. Cancer Letters, 181, 187-194.  
&lt;br /&gt;https://doi.org/10.1016/S0304-3835(02)00047-2</mixed-citation></ref><ref id="scirp.76431-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Cheng, Q., Rao, P.V. and Zigler, J.S. (2001) Effect of Perillic Acid, a Putative Isoprenylation Inhibitor, on the Cultured Rat Lens. Experimental Eye Research, 73, 239-245.</mixed-citation></ref><ref id="scirp.76431-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Dolder, S., Hofstetter, W., Wetterwald, A.C., Mühlbauer, R.C. and Felix, R. (2006) Effect of Monoterpenes on the Formation and Activation of Osteoclasts in Vitro. Journal of Bone and Mineral Research, 21, 647-655.  
&lt;br /&gt;https://doi.org/10.1359/jbmr.060111</mixed-citation></ref><ref id="scirp.76431-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Ferri, N., Arnaboldi, L., Orlandi, A., Yokoyama, K., Gree, R., Granata, A., Hachem, A., Paoletti, R., Gelb, M.H. and Corsini, A. (2001) Effect of S(-) Perillic Acid on Protein Prenylation and Arterial Smooth Muscle Cell Proliferation. Biochemical Pharmacology, 62, 1637-1645.</mixed-citation></ref><ref id="scirp.76431-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Inouye, S., Takizawa, T. and Yamaguchi, H. (2001) Antibacterial Activity of Essential Oils and Their Major Constituents against Respiratory Tract Pathogens by Gaseous Contact. Journal of Antimicrobial Chemotherapy, 47, 565-573.  
&lt;br /&gt;https://doi.org/10.1093/jac/47.5.565</mixed-citation></ref><ref id="scirp.76431-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Karp, F., Mihaliak, C.A., Harris, J.L. and Croteau, R. (1990) Monoterpene Biosynthesis: Specificity of the Hydroxylations of (-)-Limonene by Enzyme Preparations from Peppermint (Mentha piperita), Spearmint (Mentha spicata), and Perilla (Perilla frutescens) Leaves. Archives of Biochemistry and Biophysics, 276, 219-226.</mixed-citation></ref><ref id="scirp.76431-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Gonalves, J.A., Bueno, A.C. and Gusevskaya, E.V. (2006) Palladium-Catalyzed Oxidation of Monoterpenes: Highly Selective Syntheses of Allylic Ethers from Limonene. Journal of Molecular Catalysis A: Chemical, 252, 5-11.</mixed-citation></ref><ref id="scirp.76431-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Kholdeeva, O.A. (2014) Recent Developments in Liquid-Phase Selective Oxidation Using Environmentally Benign Oxidants and Mesoporous Metal Silicates. Catalysis Science &amp; Technology, 4, 1869-1889. &lt;br /&gt;https://doi.org/10.1039/c4cy00087k</mixed-citation></ref><ref id="scirp.76431-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Marmulla, R. and Harder, J. (2014) Microbial Monoterpene Transformations—A Review. Frontiers in Microbiology, 5, 346. &lt;br /&gt;https://doi.org/10.3389/fmicb.2014.00346</mixed-citation></ref><ref id="scirp.76431-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Duetz, W.A., Bouwmeester, H., Van Beilen, J.B. and Witholt, B. (2003) Biotransformation of Limonene by Bacteria, Fungi, Yeasts, and Plants. Applied Microbiology and Biotechnology, 61, 269-277. &lt;br /&gt;https://doi.org/10.1007/s00253-003-1221-y</mixed-citation></ref><ref id="scirp.76431-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Speelmans, G., Bijlsma, A. and Eggink, G. (1998) Limonene Bioconversion to High Concentrations of a Single and Stable Product, Perillic Acid, by a Solvent-Resistant Pseudomonas putida Strain. Applied Microbiology and Biotechnology, 50, 538-544.  
&lt;br /&gt;https://doi.org/10.1007/s002530051331</mixed-citation></ref><ref id="scirp.76431-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Mirata, M.A., Heerd, D. and Schrader, J. (2009) Integrated Bioprocess for the Oxidation of Limonene to Perillic Acid with Pseudomonas putida DSM 12264. Process Biochemistry, 44, 764-771.</mixed-citation></ref><ref id="scirp.76431-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Willrodt, C., Halan, B., Karthaus, L., Rehdorf, J., Julsing, M.K., Buehler, K. and Schmid, A. (2017) Continuous Multistep Synthesis of Perillic Acid from Limonene by Catalytic Biofilms under Segmented Flow. Biotechnology and Bioengineering, 114, 281-290. &lt;br /&gt;https://doi.org/10.1002/bit.26071</mixed-citation></ref><ref id="scirp.76431-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Van Rensburg, E., Molekeli, N., Van der Walt, J.P., Botes, P.J. and Van Dyk, M.S. (1997) Biotransformation of (+)-Limonene and (-)-Piperitone by Yeasts and Yeast- Like Fungi. Biotechnology Letters, 19, 779-782.  
&lt;br /&gt;https://doi.org/10.1023/A:1018344411069</mixed-citation></ref><ref id="scirp.76431-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Ferrara, M.A., Almeida, D.S., Siani, A.C., Lucchetti, L., Lacerda, P.S.B., Freitas, A., Tappin, M.R.R. and Bon, E.P.S. (2013) Bioconversion of R-(+)-Limonene to Perillic Acid by the Yeast Yarrowia lipolytica. Brazilian Journal of Microbiology, 44, 1075- 1080. &lt;br /&gt;https://doi.org/10.1590/S1517-83822014005000008</mixed-citation></ref><ref id="scirp.76431-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Fickers, P., Benetti, P.H., Wache, Y., Marty, A., Mauersberger, S., Smit, M.S. and Nicaud, J.M. (2005) Hydrophobic Substrate Utilisation by the Yeast Yarrowia lipolytica, and Its Potential Applications. FEMS Yeast Research, 5, 527-543.  
&lt;br /&gt;https://doi.org/10.1016/j.femsyr.2004.09.004</mixed-citation></ref><ref id="scirp.76431-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Gellissen, G., Kunze, G., Gaillardin, C., Cregg, J.M., Berardi, E., Veenhuis, M. and Van der Klei, I. (2005) New Yeast Expression Platforms Based on Methylotrophic Hansenula polymorpha and Pichia pastoris and on Dimorphic Arxula adeninivorans and Yarrowia lipolytica—A Comparison. FEMS Yeast Research, 5, 1079-1096.  
&lt;br /&gt;https://doi.org/10.1016/j.femsyr.2005.06.004</mixed-citation></ref><ref id="scirp.76431-ref24"><label>24</label><mixed-citation publication-type="book" xlink:type="simple">Rodrigues, M.I. and Iemma, A.F. (2005) Planejamento de Experimentos e Otimiza&amp;atilde;o de Processos. Uma estratégia sequencial de planejamento, Ed. Casa do P&amp;atilde;o, Campinas.</mixed-citation></ref><ref id="scirp.76431-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Negro, V., Mancini, G., Ruggeri, B. and Fino, D. (2016) Citrus Waste as Feedstock for Bio-Based Products Recovery: Review on Limonene Case Study and Energy Valorization. Bioresource Technology, 214, 806-815.</mixed-citation></ref><ref id="scirp.76431-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Krühne, U., Heintz, S., Ringborg, R., Rosinha, I.P., Tufvesson, P., Gernaey, K.V. and Woodley, J.M. (2014) Biocatalytic Process Development Using Microfluidic Miniaturized Systems. Green Processing and Synthesis, 3, 23-31.  
&lt;br /&gt;https://doi.org/10.1515/gps-2013-0089</mixed-citation></ref><ref id="scirp.76431-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">FAOSTAT. Food and Agriculture Organization of the United Nations Home Page.  
http://faostat3.fao.org/browse/Q/QC/E</mixed-citation></ref><ref id="scirp.76431-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Ferreira-Leit&amp;atilde;o, V., Gottschalk, L.M.F., Ferrara, M.A., Nepomuceno, A.L., Molinari, H.B.C. and Bon, E.P.S. (2010) Biomass Residues in Brazil: Availability and Potential Uses. Waste Biomass Valorization, 1, 65-76.  
&lt;br /&gt;https://doi.org/10.1007/s12649-010-9008-8</mixed-citation></ref></ref-list></back></article>